Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 411-414, February 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinha, D.
Right arrow Articles by Dao, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinha, D.
Right arrow Articles by Dao, T. L.

The Nature of Estrogen and Prolactin Effect on Mammary Tumorigenesis

Dilip Sinha, David Cooper and Thomas L. Dao

Department of Breast Surgery and Endocrine Research Laboratory, Roswell Park Memorial Institute, Buffalo, New York 14203

Increased release of pituitary prolactin as a result of placement of electrolytic lesions in the median eminence of the hypothalamus greatly accelerated the growth rate of carcinogen-induced mammary tumors in rats. Ovariectomy in these rats induced a rapid regression of tumors in spite of high plasma levels of prolactin. Grafting a pair of ovaries into ovariectomized rats with lesions of the median eminence did not alter the levels of plasma prolactin, but it did cause a rapid resumption of tumor growth. It is concluded that the prolactin stimulus to growth of mammary tumor is dependent on the presence of ovarian hormones.

Received 10/ 3/72. Accepted 11/ 9/72.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
P. M. Schyve, F. Smithline, and H. Y. Meltzer
Neuroleptic-induced Prolactin Level Elevation and Breast Cancer: An Emerging Clinical Issue
Arch Gen Psychiatry, November 1, 1978; 35(11): 1291 - 1301.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. T. KIANG and BJ. KENNEDY
Tamoxifen (Antiestrogen) Therapy in Advanced Breast Cancer
Ann Intern Med, December 1, 1977; 87(6): 687 - 690.
[Abstract] [PDF]


Home page
ScienceHome page
E. Johnson, J. Seely, W. White, and E. DeSombre
Endocrine-dependent rat mammary tumor regression: use of a gonadotropin releasing hormone analog
Science, October 15, 1976; 194(4262): 329 - 330.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.